Third Circuit upholds FTC loss in ViroPharma challenge

Proof that allegedly anticompetitive conduct occurred in the past does not show that the conduct is about to occur now, a federal appeals court has held in affirming the dismissal of the Federal Trade Commission’s case against Shire ViroPharma.

Get unlimited access to all Global Competition Review content